Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
Provided By GlobeNewswire
Last update: Oct 14, 2025
LOS ANGELES, CA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present and host institutional investor meetings at the Guggenheim 2nd Annual Healthcare Innovation Conference being held November 10-12, 2025 in Boston, MA.
Read more at globenewswire.com
